首页> 美国卫生研究院文献>BMC Cancer >Utility of 18F-fluoro-deoxyglucose emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in combination with ultrasonography for axillary staging in primary breast cancer
【2h】

Utility of 18F-fluoro-deoxyglucose emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in combination with ultrasonography for axillary staging in primary breast cancer

机译:18F-氟脱氧葡萄糖发射断层扫描/计算机断层扫描融合成像(18F-FDG PET / CT)结合超声检查在原发性乳腺癌腋窝分期中的应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundAccurate evaluation of axillary lymph node (ALN) involvement is mandatory before treatment of primary breast cancer. The aim of this study is to compare preoperative diagnostic accuracy between positron emission tomography/computed tomography with 18F-fluorodeoxyglucose (18F-FDG PET/CT) and axillary ultrasonography (AUS) for detecting ALN metastasis in patients having operable breast cancer, and to assess the clinical management of axillary 18F-FDG PET/CT for therapeutic indication of sentinel node biopsy (SNB) and preoperative systemic chemotherapy (PSC).
机译:背景技术在治疗原发性乳腺癌之前,必须对腋窝淋巴结(ALN)的参与情况进行准确评估。这项研究的目的是比较正电子发射断层扫描/计算机断层扫描与 18 F-氟脱氧葡萄糖( 18 F-FDG PET / CT)和腋窝超声检查在术前的诊断准确性AUS)用于检测可手术乳腺癌患者的ALN转移,并评估腋窝 18 F-FDG PET / CT的临床管理,以作为前哨淋巴结活检(SNB)和术前全身化疗的治疗指征( (PSC)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号